港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物医药B类股

500.811

-2.736-0.54%

涨家数：9

跌家数：20

平家数：4

市盈率：- -

高：512.805

开：504.030

低：499.921

收：503.547

成交量：7,496.91万

成交额：19.33亿

市值：3,170.31亿

流通市值：2,839.18亿

数据加载中...

总览新闻资讯

创胜集团医药-B(06628.HK)“抗CLDN18.2抗体及其诊断用途”的发明专利申请获国家知识产权局授予发明专利

港股概念追踪 | 三季报大幕拉开！AI、创新药等领域获关注投资者应如何布局三季报行情？(附概念股)

智通财经网

国产创新药“出海”如何走远走实？

哈药集团总裁芦传有被立案留置，公司称经营运转正常

亿腾嘉和(06998.HK)：GB268结直肠癌的II期临床试验IND获国家药监局批准

哈药股份64岁总裁被留置！去年薪酬超296万元，曾任三精制药董事长，公司股价曾30个交易日涨200%

红星资本局

亿腾嘉和：GB268结直肠癌II期临床试验获批

中信建投：制药、医疗器械及服务行业2026Q3前瞻

清华证研院：创新药板块景气修复与医疗器械自主可控构成9月主线

东方财富网

贝康医疗-B(02170)10月9日斥资1.88万港元回购1.5万股

腾盛博药-B(02137.HK)10月9日斥资8.5万港元回购10.1万股

康泰医学(300869.SZ)获得“彩色多普勒超声诊断系统”医疗器械注册证

海致科技集团(02706.HK)与九州通订立战略合作框架协议围绕医药流通行业的数智化转型开展战略合作

海致科技集团：与九州通订立战略合作框架协议助力医药流通行业数智化转型

南方财经网

贝康医疗-B(02170)拟斥资不超过500万元购回H股

券商10月金股出炉：电子、医药和银行增配居前，药明康德最热

东方财富网

白云山(00874)：天心制药收到国家药品监督管理局核准签发的关于厄贝沙坦氢氯噻嗪片的《药品注册证书》

德琪医药-B(06996.HK)10月9日斥资80.35万港元回购25.45万股

德琪医药-B(06996)10月9日斥资80.35万港元回购25.45万股

联环药业创新药项目取得新进展，能否持续提振公司业绩？

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/BK1574/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":500.8114,"timestamp":1791792495045,"preClose":503.54697,"halted":0,"volume":74969144,"delay":0,"changeRate":-0.005433,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-2.735565,"latestTime":"10-12 16:00:00","open":504.02963,"high":512.8047,"low":499.92114,"amount":1932609332.5,"amplitude":0.025586,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791855000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791768600000,1791777600000],[1791781200000,1791792000000]],"pbRate":3.724844,"peRate":165.446177,"turnoverRate":0.002808,"increases":9,"decrements":20,"flats":3,"marketCap":317031331104,"floatMarketCap":283917567336},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":512.8047,"amplitude":0.025586,"preClose":503.54697,"low":499.92114,"pbRate":"3.755372","latestPrice":500.8114,"volume":74969144,"delay":0,"open":504.02963,"prevYearClose":556.26263,"prevWeekClose":503.547,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":510.536,"twentyDayClose":483.155,"sixtyDayClose":473.886,"secType":"PLATE","market":"HK","turnoverRate":0.002808,"peRate":166.986761,"marketCap":317031331104,"floatMarketCap":283917567336,"timestamp":1791792495045,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":9,"down":20,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674842333","title":"创胜集团医药-B(06628.HK)“抗CLDN18.2抗体及其诊断用途”的发明专利申请获国家知识产权局授予发明专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2674842333","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674842333?lang=zh_cn&edition=fundamental","pubTime":"2026-10-12 08:17","pubTimestamp":1791764278,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1574","BK1515","09939","06628"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674417038","title":"港股概念追踪 | 三季报大幕拉开！AI、创新药等领域获关注 投资者应如何布局三季报行情？(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674417038","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674417038?lang=zh_cn&edition=fundamental","pubTime":"2026-10-12 07:06","pubTimestamp":1791759963,"startTime":"0","endTime":"0","summary":"从研报角度看，机构普遍看好三季报绩优股表现。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20261012/20261012070628_23221.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20261012/20261012070628_23221.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["159992","QTOC","MEDX","06978","BK4585","KCAI","LNGR","AIPO","VXUS","AGIX","BK1161","BK1574","CHAT","IBBQ","VTHR","ARTY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674848723","title":"国产创新药“出海”如何走远走实？","url":"https://stock-news.laohu8.com/highlight/detail?id=2674848723","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674848723?lang=zh_cn&edition=fundamental","pubTime":"2026-10-11 23:15","pubTimestamp":1791731700,"startTime":"0","endTime":"0","summary":"■张敏今年以来，国产创新药全球化进程持续向前，多项海外授权交易落地，行业也在全球临床与注册实践中接受检验、迭代成长。一方面，国产创新药持续通过License-out（对外授权）模式叩开国际市场大门。今年以来，我国创新药对外授权交易总额已突破1200亿美元。另一方面，国产创新药在海外临床开发、药品注册等环节，持续迎来考验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610113892128710.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610113892128710.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IBBQ","BK1161","159992","06978","LNGR","BK1574","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674807810","title":"哈药集团总裁芦传有被立案留置，公司称经营运转正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2674807810","media":"经理人","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674807810?lang=zh_cn&edition=fundamental","pubTime":"2026-10-11 19:53","pubTimestamp":1791719580,"startTime":"0","endTime":"0","summary":"此番集团总裁被监察机关立案留置，也引发市场对于案件细节、涉案事由的关注。不过截至目前，哈药股份公告并未披露芦传有被立案调查的具体事由，相关调查进展有待监察机关后续公布。芦传有深耕哈药多年，手握经营管理权限，此次被立案留置，后续调查结论或将影响市场对哈药集团内部管理的审视。哈药股份当前生产经营暂未受冲击，但后续需持续关注监察机关调查结果、上市公司信息披露以及人事调整进展。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-11/doc-iniuwcye0611501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01477","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674817600","title":"亿腾嘉和(06998.HK)：GB268结直肠癌的II期临床试验IND获国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2674817600","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674817600?lang=zh_cn&edition=fundamental","pubTime":"2026-10-11 19:22","pubTimestamp":1791717736,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1161","BK1574","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674171188","title":"哈药股份64岁总裁被留置！去年薪酬超296万元，曾任三精制药董事长，公司股价曾30个交易日涨200%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674171188","media":"红星资本局","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674171188?lang=zh_cn&edition=fundamental","pubTime":"2026-10-11 18:44","pubTimestamp":1791715440,"startTime":"0","endTime":"0","summary":"去年薪酬超296万元，曾任三精制药董事长；公司股价曾30个交易日涨200%，上半年净利增58%红星资本局10月11日消息，今日，哈药股份发布公告称，于近日收到相关监察委员会关于公司董事、总裁芦传有的《立案通知书》和《留置通知书》。2025年，芦传有从公司获得的税前薪酬总额为296.68万元。期间，哈药股份曾先后6次发布股票交易异常波动公告。业绩层面，哈药股份2025年实现营收159.64亿元，同比下降1.31%；归母净利润3.62亿元，同比下降42.50%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-10-11/doc-iniuwcyi8828929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0012","600664","BK0188","01477","BK0028","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674881734","title":"亿腾嘉和：GB268结直肠癌II期临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2674881734","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674881734?lang=zh_cn&edition=fundamental","pubTime":"2026-10-11 18:41","pubTimestamp":1791715260,"startTime":"0","endTime":"0","summary":"10月11日，亿腾嘉和（06998）发布公告，宣布其高度差异化创新的PD-1/CTLA-4/VEGF三特异性抗体GB268联合化疗在晚期结直肠癌的II期临床试验申请已于2026年10月9日获得中国国家药品监督管理局批准。这一进展标志着GB268的临床开发方案获得监管机构初步认可，为公司的后续推进奠定了坚实基础。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610113892081935.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610113892081935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BMED","PSYK","BK1583","BK1161","BK1574","IBBQ","06998","MDTX","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674817283","title":"中信建投：制药、医疗器械及服务行业2026Q3前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2674817283","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674817283?lang=zh_cn&edition=fundamental","pubTime":"2026-10-11 18:25","pubTimestamp":1791714300,"startTime":"0","endTime":"0","summary":"2026年上半年，医药行业全板块营业收入同比增长1.81%，扣非归母净利润同比增长6.05%。整体看，医药行业收入和扣非净利润在2026年上半年均迎来改善趋势。2018年加入中信建投证券研究发展部。团队负责研究医疗器械与医疗服务各细分赛道的发展趋势和投资机遇。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-10-11/doc-iniuwcxz5681613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IEIH","601066","HART","BK1574","MEDX","01477","PTH","MDEV","BK1583","BK1191","LGHT","09996","BK0276","GDOC","LNGR","AGNG","159883","RSPH","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674899603","title":"清华证研院：创新药板块景气修复与医疗器械自主可控构成9月主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2674899603","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674899603?lang=zh_cn&edition=fundamental","pubTime":"2026-10-10 15:28","pubTimestamp":1791617326,"startTime":"0","endTime":"0","summary":"上证报中国证券网讯（记者张玮华）清华大学全球证券市场研究院（以下简称“清华证研院”）发布《中国上市公司市值分析月度报告（2026年9月）》。清华证研院院长助理、中国上市公司市值管理研究负责人迟永胜接受上证报记者采访时表示，9月A股市场整体呈现调整回落、估值同步压缩的运行态势；行业方面，房地产、医药生物、银行等板块逆势上涨，价值防御风格占优特征清晰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11215,202610103891917365.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11215,202610103891917365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["HART","MEDX","BK1161","BK1574","159992","LNGR","BK1100","06978","AGNG","09996","GDOC","LGHT","IBBQ","PTH","BK1583","159883","IEIH","RSPH","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674577148","title":"贝康医疗-B(02170)10月9日斥资1.88万港元回购1.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674577148","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674577148?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 22:07","pubTimestamp":1791554850,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B(02170)发布公告，于2026年10月9日斥资1.88万港元回购1.5万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02170","BK1597","BK1574","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674685728","title":"腾盛博药-B(02137.HK)10月9日斥资8.5万港元回购10.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674685728","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674685728?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 22:02","pubTimestamp":1791554542,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","02137","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674855721","title":"康泰医学(300869.SZ)获得“彩色多普勒超声诊断系统”医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2674855721","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674855721?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 18:56","pubTimestamp":1791543398,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康泰医学(300869.SZ)发布公告，公司于近日取得了由河北省药品监督管理局颁发的《中华人民共和国医疗器械注册证》，该产品为：“彩色多普勒超声诊断系统”。彩色多普勒超声诊断系统医疗器械注册证的首次取得，有利于丰富公司产品线，进一步提高公司的核心竞争力，对公司发展具有正面影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505354.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGNG","BK1574","PTH","BK0251","BK1100","159883","300869","LGHT","MDEV","09996","RSPH","BK1583","LNGR","GDOC","MEDX","IEIH","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674685524","title":"海致科技集团(02706.HK)与九州通订立战略合作框架协议 围绕医药流通行业的数智化转型开展战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2674685524","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674685524?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 18:52","pubTimestamp":1791543156,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1117","BK1574","09939","02706","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674856197","title":"海致科技集团：与九州通订立战略合作框架协议 助力医药流通行业数智化转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2674856197","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674856197?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 18:52","pubTimestamp":1791543120,"startTime":"0","endTime":"0","summary":"南财智讯10月9日电，海致科技集团（02706.HK）发布自愿公告，公司近期与九州通医药集团股份有限公司订立战略合作框架协议。根据协议，双方将围绕医药流通行业的数智化转型开展战略合作，以图谱解决方案与智能体为载体，依托多模数据库与本体技术，构建数据与业务语义底座及智能体应用两级赋能架构，为九州通供应链业务提供智能决策支持。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610093891382266.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610093891382266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0039","BK0188","600998","BK0187","BK0077","BK0028","BK0097","BK0201","BK1117","02706","BK0250","BK0183","BK0012","09939","BK1161","BK0146","BK0196","159938","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674885598","title":"贝康医疗-B(02170)拟斥资不超过500万元购回H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674885598","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674885598?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 18:42","pubTimestamp":1791542526,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B 发布公告，董事会欣然宣布，其拟根据购回授权行使其权力，且本公司将根据市场状况及购回授权的条款不时于公开市场购回H股，金额不超过人民币500万元。本公司拟以其自有财务资源而非香港联合交易所有限公司H股上市所得款项为股份购回计划提供资金。董事会认为， H股目前的交易价格低估了本公司的内在价值及业务前景，而股份购回计划将提升股东价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","BK1574","02170","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674685509","title":"券商10月金股出炉：电子、医药和银行增配居前，药明康德最热","url":"https://stock-news.laohu8.com/highlight/detail?id=2674685509","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674685509?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 18:11","pubTimestamp":1791540660,"startTime":"0","endTime":"0","summary":"A股进入四季度交易时间，各大券商在10月更加青睐哪些板块和标的？整体来看，行业方面，电子是券商10月金股中权重较大的行业，且占比突出。权重增加最多的行业则是电子、医药和银行。具体到个股方面，开源证券研报数据显示，根据全市场35家券商发布的金股去重统计后，药明康德（603259）的热度最高，合计被各家券商10月金股推荐的次数最多。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/1405,202610093891371865.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/1405,202610093891371865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["LU2242644610.SGD","BK1141","LU0052750758.USD","LU1979443071.USD","LU2495084118.USD","LU1046422090.SGD","LU1303224171.USD","LU0106959298.USD","LU2125910500.SGD","LU0456842615.SGD","LU0469268626.HKD","LU1808992512.USD","LU1997245177.USD","LU0348767384.USD","161121","LU0611395673.USD","LU1719994722.HKD","LU1934453819.USD","BK0216","LU2045819591.USD","159938","BK1576","LU2328871848.SGD","BK1161","LU0708995583.HKD","LU0572944931.SGD","LU0320764599.SGD","LU1997244956.HKD","LU0327786744.USD","IE00B5MMRT66.SGD","BK1515","BK1583","LU1997245094.SGD","IE00BPRC5H50.USD","09939","IE00B543WZ88.USD","LU1770034418.SGD","LU0700851271.USD","02359","603259","BK1574","KCE","LU1969619763.USD","LU2488822045.USD","LU1251922891.USD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674485895","title":"白云山(00874)：天心制药收到国家药品监督管理局核准签发的关于厄贝沙坦氢氯噻嗪片的《药品注册证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674485895","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674485895?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 17:55","pubTimestamp":1791539748,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山 发布公告，近日，广州白云山医药集团股份有限公司控股子公司广州白云山天心制药股份有限公司收到国家药品监督管理局核准签发的关于厄贝沙坦氢氯噻嗪片的《药品注册证书》。2025年4月2日，天心制药向国家药品监督管理局递交药品注册申请，于2025年4月30日获得受理。截至目前，天心制药在厄贝沙坦氢氯噻嗪片研发项目上已投入研发费用合计约人民币1291.53万元(未审计)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1606","BK0196","BK0070","BK1574","BK1197","BK0183","01477","BK1515","600332","BK0175","BK0097","BK0028","BK0096","BK0239","BK0188","BK1521","BK0012","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674683009","title":"德琪医药-B(06996.HK)10月9日斥资80.35万港元回购25.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674683009","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674683009?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 17:40","pubTimestamp":1791538838,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1574","06996","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674300948","title":"德琪医药-B(06996)10月9日斥资80.35万港元回购25.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674300948","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674300948?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 17:40","pubTimestamp":1791538838,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，该公司于2026年10月9日斥资80.35万港元回购25.45万股股份，每股回购价格为3.07-3.27港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","06996","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674421834","title":"联环药业创新药项目取得新进展，能否持续提振公司业绩？","url":"https://stock-news.laohu8.com/highlight/detail?id=2674421834","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674421834?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 15:40","pubTimestamp":1791531601,"startTime":"0","endTime":"0","summary":"联环药业创新药项目取得新进展，能否提振公司业绩？近期，联环药业1类创新药LH-1801正式提交申报材料，进入CDE受理等待阶段，其创新转型之路取得阶段性成果。联环药业此前在公告中坦承，预计该项目在未来相当一段时间内不会对公司的营业收入和经营业绩产生重大影响。在联环药业披露LH-1801项目进展后，公司股票于10月8日强势涨停，10月9日开盘后继续上冲，股价走势直观反映出资本市场对公司发展前景的乐观预期。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202610/09/20261009838314.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202610/09/20261009838314.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20261009/32391452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LNGR","IBBQ","MEDX","BK0239","600513","06978","BK1161","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":2,"totalSize":249,"code":"91000000","status":"200"}]}}